Background: The early effects of childhood acute lymphoblastic leukemia (ALL) include decreased physical function, bone mineral density (BMD/g/cm 2 ), and health-related quality of life (HRQL).
INTRODUCTION
Each year, more than 3,000 new cases of childhood acute lymphoblastic leukemia (ALL) are diagnosed in the United States. 1 At diagnosis, children experience motor problems, suggesting that the cancer itself results in functional impairment. 2, 3 Thirty-six percent of children with ALL reported musculoskeletal pain at diagnosis 4 ; as early as 3 days after vincristine administration, areflexia, weakness and atrophy of the Abbreviations: ALL, acute lymphoblastic leukemia; APN, advanced practice nurse; BMD, bone mineral density; COG, Children's Oncology Group; DEXA, dual-energy X-ray absorptiometry; HRQL, health-related quality of life; MDA, MD Anderson; PT, physical therapist; SJCRH, St. Jude Children's Research Hospital extremities, muscle pain/cramps, and decreased range of motion are noted. 2, [5] [6] [7] [8] Decreased ankle dorsiflexion strength, knee extension, and loss of functional mobility are common and may be seen as early as 4-5 months into therapy. 9, 10 One year or more after completing ALL therapy, children and young adults (5.1-25.2 years of age) had delayed gross motor skills, poor balance, decreased strength, and decreased ankle range of motion; these impairments are responsible for subsequent dysfunction of balance and postural control. [11] [12] [13] Pain and fatigue contribute to a cycle of reduced activity, diminished strength and fitness, increased fatigue, and decreased quality of life. [14] [15] [16] Children's bone mineral density (BMD) is reduced early in the course of therapy and remains low after completion of chemotherapy, which is associated with type and dose of corticosteroids, methotrexate exposure, cranial irradiation, and physical inactivity. 17, 18 With a survival rate exceeding 93%, 19, 20 children with ALL have a potentially positive future if intervention can diminish early loss of physical function and modify the later effects of therapy. Recent reports 21, 22 urge early physical activity to minimize the sequelae of treatment in childhood cancer survivors; prescribed physical activity, even at low intensity and duration levels, has demonstrated changes in remarkably short periods of time in young cancer patients and survivors. 9, 18, [23] [24] [25] [26] However, the physical activity interventions for ALL that have been tested have started after functional loss has occurred, involved small and/or nonrandomized samples, been of short duration, and had minimal or no follow-up to monitor behavior sustainability and durability.
We conducted a randomized trial to evaluate a motivation-based physical activity program beginning within 10 days of diagnosis and extending throughout treatment. We hypothesized that, compared to the usual care group, the intervention group at T 3 would maintain or increase BMD over baseline values and demonstrate increased physical function, endurance, and health-related quality of life (HRQL) at 8 (T 1 ), 15 (T 2 ), and 135 weeks (T 3 ). Eligible children were 4 through 18.99 years old; enrolled on or being treated per the SJCRH or Children's Oncology Group (COG) frontline ALL protocol; had started ALL therapy within the past 10 days; could speak and understand English and had at least one parent who could speak, read, and write English; did not have cerebral palsy, second malignancy, chromosome breakage syndrome, or severe congenital immunodeficiency; had the written informed consent of at least one parent/guardian; and provided assent as appropriate. The lower age limit was selected to allow comparison of study outcome measures with existing normative data; the upper age threshold was selected to limit participants to those on the two frontline protocols.
METHODS

Intervention
The intervention consisted of two components: a strategy 27,28 aimed at supporting motivation for long-term behavior change and a set of routine physical therapy exercises targeting strength, range of motion, gross motor skills, and endurance. Advanced practice nurse (APN) visits (in hospital or clinic) occurred twice weekly for the first 4 weeks, once weekly during weeks 5-8, and monthly during weeks 9-135. The physical therapist (PT) visits (in hospital or clinic) occurred once weekly during weeks 1-4, once every other week during weeks 5-8, and once monthly during weeks 9-135.
APN visits
The goal was to support the patient and their family to become increasingly self-reliant in initiating and sustaining exercise that would help to prevent or modify both early and late effects of therapy. All interactions were directed at meeting three primary needs of the patient and family: relatedness, competency, and autonomy. The APN engaged the patient and parents in dialogue that consistently emphasized the volitional nature of participation in the program and avoided coercive language ("we would like for you to," "you should"). They continually emphasized the child/parent perspective, providing personalized, rather than generic, information.
PT visits
The stretching, strengthening, and countermovement jumping activities were tested in a pilot study among children with ALL 29 based on principles pertaining to frequency, duration, and intensity of exercise 30 and on the Winningham Program 31 modified for the pediatric ALL population. 9 Activities within categories were equivalent and achieved the same therapeutic aims; frequency, intensity, and duration of the activities were consistent for all ages. The child's health status guided the PT's intervention approach: for example, if a child was nauseated, the caregiver might perform a passive stretch. The participants were encouraged to perform their exercises at home independently or with parental support 5× weekly 30 min per session.
Usual-care attention/control
This group received attention-control visits from the PT at the same intervals and in the same location as the treatment group in order to match the procedures of the intervention group. While the current standard of care for patients with newly diagnosed ALL is activity as tolerated, there is an increased risk of reduced ankle dorsiflexion during vincristine therapy-the predominant reason for PT referral. 7 We recommended that patients and parents/guardians in the usual care group perform passive ankle stretching to slow the limitation of ankle range of motion. At each visit, the PT instructed/reinforced the patient and caregiver on how to safely perform ankle dorsiflexion passive stretches and trunk stretching exercises at home for 30 sec 5×
weekly. Similarly, the APN visits occurred on the same schedule as for the intervention group, and the APN inquired in a neutral manner about how the patient and family were doing.
Physical assessments
An assessment practice trial was done 1-2 days prior to the baseline assessment to avoid any learning effects; a second practice trial was completed 2 days before the T 1 assessment, approximately 6-7 weeks after chemotherapy began. T 2 assessment occurred within approximately 8-9 weeks after completion of induction therapy and the T 3 assessment occurred approximately 135 weeks after the start of chemotherapy.
Outcomes
Dual-energy X-ray absorptiometry (DEXA) determined BMD (g/cm 2 ) of the lumbar spine was measured at diagnosis and at week 135 (T 3 ) anteriorly in L1-L4 and laterally in L2-L4 using the GE Lunar Prodigy (Atlanta and Toronto) or the Hologic (SJCRH and MDA). As trabecular bone (lumbar spine) is metabolically more active than cortical bone (total body, hip), the effects of the intervention should be more readily detected by assessing trabecular bone. Consistent with ongoing studies at SJCRH, we contracted with Bioclinica, Inc. (Newtown, PA) to assure site calibration and quality control for comparability of data across the sites and between the two different manufacturers and models of equipment. Height, weight, age, race, and gender-adjusted corrected Z-scores constituted the BMD measures and were provided directly to us by Bioclinica. These data are based on The National
Health and Nutrition Surveys and are incorporated into the manufacturer's software for the GE Lunar Prodigy and Hologic.
Physical function
Changes were measured in muscular strength (hand grip, knee extension, dorsiflexion) and ankle range of motion (measured by goniometry)
at T 0 -T 3 , 32 cardiovascular endurance on the 6-Minute Walk Test, 33 and motor proficiency on the Bruininks-Oseretsky Test of Motor Proficiency Short Form (BOTSF-2). 34
HRQL
The Child Health Questionnaire, in parallel parent and child forms, 
Physical activity patterns
Children's physical activity patterns were evaluated at each assessment period for 7 days using accelerometers (SenseWear Pro III, BodyMedia, Pittsburgh, PA). Successful accelerometer data collection in children with leukemia as young as 4 years 36 has been reported. Short gaps (<20 min) or periods specified for light activity (e.g., changing
clothes or showering) were filled by using the mean of the 5-min periods before and after the gap. Unexplained gaps and periods longer than 20 min were tracked across days, and participants with more than 1 hr of missing data were assumed to be noncompliant for the designated day (data were recoded as missing). Proprietary algorithms provided the estimated energy expenditure (EE) data for each minute, but customized SAS programs, developed by the consultant to the project, were used to create summary data files that included total daily EE estimates (kcal/day, kcal/kg/day) and the percentage of time spent in different intensities of activity (rest, light, moderate, vigorous). Participants were provided with the same SP3 unit (tracked by serial number)
for each assessment period to minimize any risk due to intermonitor variability.
Independent variables 2.5.1 Demographics
Child/parental age; gender; race/ethnicity; mother's, father's, and patient's highest level of education; total household income; and parent marital status were obtained from the medical record or data collection forms.
Diagnosis-related information
ALL immunophenotype, diagnosis date, and therapy prescribed were collected from the medical record.
Child data
Height and weight were used to interpret and compare study results with normative data on the physical function and bone density measures and to calculate the accelerometer data.
Somatic/emotional distress
To assess the impact of chemotherapy side effects on the physical performance and HRQL measures at baseline and T 1 , we administered two of the five subscales from the Behavioral Affective Somatic Experiences Scale. 37,38
Adherence to the intervention
Three measures of adherence were included in the study: number of days accelerometer was worn at each study assessment point (7 days), total number of visits/phone calls with the PT (37 visits) and APN (43 visits), and daily physical activity logs (5 days weekly).
Sample size and randomization
Sample size was based on a standardized effect size of 0.5 reported for BMD in previous longitudinal studies lasting longer than 2 years and modified for sick children. 39 With 38 evaluable patients in each group, this study had 80% power to detect this effect size with a withinparticipant correlation coefficient of 0.5 and a type I error of 0.05; the study had 86% power to detect the same effect size on each of the HRQL and physical function measures. On the basis of estimates from SJCRH institutional data, we estimated a 15% refusal rate and a withdrawal/relapse rate of 6%; we set an enrollment/retention goal of 82 participants.
All 211 eligible children were approached to participate in the study. Although 122 children were enrolled, 15 withdrew prior to randomization, with parents citing being too overwhelmed to participate in the study as their primary reason for withdrawal (Figure 1 ).
Randomization was done centrally at SJCRH using the randomization scheme proposed by Zelen. 40 The study participants were Stratified, blocked randomization was used to allocate participants within each of the 12 strata to one of the two groups so that approximately one-half of the participants in a given stratum were assigned to each arm.
Blinding
PTs who performed the functional assessments T 0 -T 3 were not informed about group assignment.
Statistical methods
Descriptive statistics and P values based on chi-square or Fisher's exact tests are provided for demographic variables in the intervention and usual care groups. A linear mixed model estimated the effects of group assignment on BMD. We performed analyses with and without adjustment for the stratification variables (age group, sex, and protocol), and the results were similar. Because some strata had very few participants, we reported the result without adjustment. 41, 42 Similar analyses were performed for physical function and parent-and child-reported HRQL. Descriptive statistics are given for these outcomes at each time point in both groups, and P values based on two-sample t tests or
Wilcoxon rank sum tests were calculated for testing differences from T 0 to T 3 between the two groups. Similar analyses were done for HRQL reported by parents and children across the four study assessments.
P values for comparison of scores between parents and children were calculated based on paired t-tests. Finally, we combined both study groups and evaluated the associations between BMI and HRQL with 
RESULTS
In the intervention group, 36 of 53 patients and parents completed all four physical performance and HRQL assessments; in the usual care group, 41 of 54 patients and parents completed all four assessments.
For the BMD assessments (T 0 and T 3 ), 51 in the intervention group and 52 in the usual care group completed T 0 , and 33 in the intervention group and 40 in the usual care group completed T 3 . There were no differences between the intervention (n = 53) and usual care (n = 54) groups on age, sex, race, mother's educational attainment, or BMD at baseline. The patients were predominantly white, male, and diagnosed between 4 and 9 years or 10 and 14 years, and most mothers had completed college (Tables 1 and 2) . Figure 2 ). There were no vertebral fractures in either of the study groups.
The usual care group scored better on left active ankle dorsiflexion (a specifically prescribed exercise for this group) at T 3 than the intervention group did (P = 0.04) (Supplementary Table S1 ). Although both groups increased their activity level (physical activity, vigorous F I G U R E 2 Mean plot with SEM error bars for BMD at T 0 and T 3 activity) from T 0 to T 3 , the differences were not significant. Both groups' activity levels declined at T 2 , likely a function of intensification of therapy. 43 Although there were minimal group differences at T 3 , children consistently scored their quality of life better (physical functioning, emotional-behavioral role, physical role, and bodily pain) than did the parent across time points (Supplementary Table S2 ). At T 2 and T 3 , children and parents were more similar in their assessments regarding mental health.
TA B L E 2 Bone mineral density across time points
Most participants in both groups wore their accelerometers 7 days as prescribed (T 1 , intervention = 82%, usual care = 84%; T 2 , intervention = 89%, usual care = 87%; T 3 , intervention = 79%, usual care = 94%); the distribution of the number of wear sessions was similar between the two groups (P = 1.00 at T 1 , 1.00 at T 2 , and 0.13 at T 3 ).
There were no differences between the groups when frequency/duration of countermovement jumps (intervention) were compared to frequency/duration of ankle (P = 0.43) and trunk (P = 0.39) rotations (usual care). There were no differences between the groups relative to APN (P = 0.12) and PT (P = 0.43) missed appointments (intervention, missed APN visits, mean = 4.39, SD = 5.41; usual care, missed APN visits, mean = 2.49, SD = 3.60; intervention group, missed PT visits, mean = 6.98, SD = 5.69; usual care missed PT visits, mean = 5.69, SD = 4.68).
We combined the two parent groups and the two patient groups to examine to what extent any of our variables in isolation might affect T 3 BMD (Table 3) . These univariate analyses provided information about impairments and quality of life factors to target in subsequent studies.
All models were adjusted for baseline BMD Z-scores by including the baseline score in each model. 
DISCUSSION
A physical activity program combined with a behavior-change strategy for the duration of ALL treatment did not improve BMD, HRQL, or physical function compared to usual care. Our findings are, however, consistent with a long-term study in which a home-based intervention was found to be no more effective than usual care to improve BMD or physical function in 51 children with ALL, primarily due to poor compliance 44 ; we too documented that vigorous exercise decreased in the intervention group from 37 to 16 min per day from baseline to T 3 , consistent with poor adherence to the intervention.
While other studies 18, [22] [23] [24] [25] [26] have shown improvement in these outcomes in late maintenance or survivorship, our study did not generate any data for intervals when children were completely off drug treatment. Beginning shortly after diagnosis and following participants through the end of therapy, however, may have resulted in the study participants/parents simply being too sick/overwhelmed particularly at T 0 -T 2 to complete the intervention with the frequency and intensity necessary to improve function; they eventually may have experienced intervention fatigue over the 30-month timeframe.
Unsupervised exercise was likely not a sufficient intervention to prevent loss of structure or function during the intensive chemotherapy required to cure disease. Unlike our pilot study, 29 in which the identical exercises were administered during the maintenance phase of chemotherapy and provided for weekly interventionists' contact, this intervention tapered to monthly interventionists' contact after 8 weeks.
Selection bias was certainly a factor in this study. While participants did not differ from nonparticipants by age or sex, it is possible that children who were sicker or who had more severe musculoskeletal symptoms at diagnosis elected not to participate. A number of parents and children refused participation after initially agreeing to enroll; parents who withdrew prior to and immediately after randomization reported "being unable to think" and not being fully aware of study participation requirements. Avoidance, extreme anxiety, and re-experiencing of events related to their child's diagnosis are reported by nearly all parents in the first two weeks after diagnosis. 45 Finally, parental concerns about radiation exposure reduced the number of evaluable T 3 DEXA scans.
Our findings were consistent with previous reports in that children with greater mass and strength had better BMD outcomes. 46 Joyce et al. 47 Finally, prospective studies have indicated that a one-standard deviation decrease in bone mass is linked to a 1.5-to 3-fold increase in the relative risk of fracture. 50 While the BMD Z-scores in this study were only slightly decreased from the mean, they can be used to counsel patients and parents about healthy lifestyle choices when bone mineral accrual is most active-during accelerated growth and development.
This study offers a number of insights for future studies. First, by offering study participation at maintenance, in contrast to within 10 days after diagnosis, parents and children will have had a considerable period of time to adjust to the diagnosis and to have hurdled the worst of treatment and disease effects. Fear, anxiety, symptoms, and overall well-being will no longer be the significant threats that they were at diagnosis, thereby potentially facilitating greater participation and commitment to the intervention.
Second, we support more frequent contact with the interventionists. While early in the intervention program, the children are learning new skill sets and coping skills, there needs to be the continuing support and emphasis on the lifelong commitment to physical activity to moderate the late effects of therapy.
Finally, different strategies for categories of patients may need to be considered. These might include individualized intense rehabilitation focused on motor impairments and fitness for children who find it difficult to be active on their own and/or the use of low-magnitude stimulation 51 to augment activity in those who are too ill or too fatigued to exercise at sufficient intensity. Pharmacologic agents may be necessary for children with low bone density and associated fracture 52 who lack the capacity to exercise because of pain and mobility limitations.
Further study is needed to optimize patient/parent exercise commitment, identify the ideal timing of late or posttherapy exercise programs, and work toward therapy changes that would mitigate decreases in BMD, HRQL, and physical function.
